Editas Medicine EDIT
NASDAQ EDIT
$2.59 +0.08 (+3.19%)
At close: Sep 29, 2026 · 4:00 PM EDT

Editas Medicine (EDIT) Restructuring Costs (2024 - 2025)

Updated

Editas Medicine (EDIT) posted Restructuring Costs of $26.08 million for Q2 2025, down 36.2% from the prior quarter.

Analysis

Editas Medicine (EDIT) Restructuring Costs (2024 - 2025) Analysis & Trends

For FY2024, Editas Medicine's Restructuring Costs came in at $12.23 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Editas Medicine 234.09 Mn -477.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 26.08 Mn
Mar 31, 2025 40.85 Mn
Dec 31, 2024 12.23 Mn
API Access

Editas Medicine Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=EDIT&period=max&api_key=YOUR_API_KEY